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OBJECTIVE—Transient receptor potential (TRP) channel–in-
duced cation influx activates human monocytes, which play an
important role in the pathogenesis of atherosclerosis. In the
present study, we investigated the effects of high glucose–
induced oxidative stress on TRP channel expression in human
monocytes.
RESEARCH DESIGN AND METHODS—Human monocytes
were exposed to control conditions (5.6 mmol/l D-glucose), high
glucose (30 mmol/l D-glucose or L-glucose), 100 mol/l peroxyni-
trite, or high glucose in the presence of the superoxide dismutase
mimetic tempol (100 mol/l). TRP mRNA and TRP protein
expression was measured using quantitative real-time RT-PCR
and quantitative in-cell Western assay, respectively. Calcium
influx and intracellular reactive oxygen species were measured
using fluorescent dyes.
RESULTS—Administration of high D-glucose significantly in-
creased reactive oxygen species. High D-glucose or peroxynitrite
significantly increased the expression of TRP canonical type 1
(TRPC1), TRPC3, TRPC5, TRPC6, TRP melastatin type 6
(TRPM6), and TRPM7 mRNA and TRPC3 and TRPC6 proteins.
High D-glucose plus tempol or high L-glucose did not affect TRP
expression. Increased oxidative stress by lipopolysaccharide or
tumor necrosis factor- increased TRP mRNA expression,
whereas the reduction of superoxide radicals using diphenylene
iodonium significantly reduced TRP mRNA expression. In-
creased TRPC3 and TRPC6 protein expression was accompanied
by increased 1-oleoyl-2-acetyl-sn-glycerol–induced calcium in-
flux, which was blocked by the TRPC inhibitor 2-aminoethoxy-
diphenylborane. TRPC6 mRNA was significantly higher in
monocytes from 18 patients with type 2 diabetes compared with
28 control subjects (P  0.05).
CONCLUSIONS—High D-glucose–induced oxidative stress in-
creases TRP expression and calcium influx in human monocytes,
pointing to a novel pathway for increased activation of mono-
cytes and hence atherosclerosis in patients with diabetes.
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Cardiovascular complications due to atheroscle-rotic disease are a frequent cause of morbidityand mortality in patients with diabetes (1).Epidemiologic studies and preliminary interven-
tion studies have shown that hyperglycemia is a direct and
independent risk factor for cardiovascular disease (2).
Atherogenesis has been considered to be an inflammatory
disease with accumulation of monocytes within the artery
wall (3). Monocytes are transitional cells, with a short
half-life due to rapid differentiation into macrophages,
and they are rapidly recruited to sites of inflammation
(4,5). Monocyte activation, adhesion to the endothe-
lium, and transmigration into the subendothelial space
are key events in early pathogenesis of atherosclerosis.
The mechanisms by which high glucose supports mono-
cyte-associated atherosclerosis are only partially known.
Mononuclear blood cells from patients with diabetes show
increased generation of reactive oxygen species because
of chronic high glucose levels (6–8). An increased activa-
tion of monocytes from patients with diabetes is associ-
ated with elevated protein kinase C activity and increased
cytosolic calcium concentrations (9–11). Elevated trans-
membrane calcium influx may be mediated by increased
transient receptor potential canonical (TRPC) channels.
Until now, only few studies addressed transient receptor
potential (TRP) expression under diabetic high glucose
conditions. One study observed TRPC type 1 (TRPC1),
TRPC4, and TRPC6 regulation and impaired capacitative
calcium entry in vessels of diabetic patients compared
with nondiabetic human vessels (12). As TRPC channels
have been identified in several cell types including periph-
eral blood monocytes (13,14), the present study was aimed
at elucidating the effects of high glucose and oxidative
stress on TRP expression and their functional relevance in
mediating calcium influx.
RESEARCH DESIGN AND METHODS
Preparation of cells. Human monocytes were obtained from heparinized
blood of healthy control subjects. All subjects gave written informed consent,
and the study was approved by the local ethics committee. Monocytes were
separated using superparamagnetic polystyrene beads coated with a primary
monoclonal antibody specific for the CD14 membrane antigen expressed on
human monocytes (Invitrogen, Groningen, Germany) and resuspended in
Hanks balanced solution containing (in mmol/l) NaCl 136, KCl 5.40, CaCl2 1,
KH2PO4 0.44, Na2HPO4 0.34, HEPES 10, pH 7.4. Monocytes were counted in
Neubauer chamber and adjusted in each experiment.
To evaluate the effects of high glucose and oxidative stress on TRP channel
expression, monocytes were exposed to 5.6 mmol/l D-glucose (control), 30
mmol/l D-glucose, or 100 mol/l peroxynitrite (ONOO) for 4 h. Additional
experiments were performed using 30 mmol/l L-glucose or 30 mmol/l D-glucose
in the presence of the superoxide dismutase mimetic tempol (TMP, 100
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mol/l). We also evaluated the effects of lipopolysaccharide-induced oxidative
stress, tumor necrosis factor- (TNF-)-induced activation of NADPH oxi-
dase, and production of superoxide radicals as well as reduction of superox-
ide radicals using diphenylene iodonium. Next, the effects of selective
inhibition of phosphatidylcholine-specific phospholipase C by tricyclodecan-
9-yl xanthogenate (D609) or the inhibition of phospholipase C activation by
1-[6-[((17)-3-methoxyestra-1,3,5 [10]-trien-17-yl)amino[hexyl]-1H-pyrrole-2,5-
dione (U73122) on TRP expression in monocytes.
RNA isolation and reverse transcriptase. Total RNA was isolated from
monocytes using the RNeasy mini kit including RNase-free DNase set (Qiagen,
Hilden, Germany). Using the Transcriptor first-strand cDNA synthesis kit
(Roche Diagnostics, Mannheim, Germany), cDNA was synthesized from 2 g
of total RNA using oligo dT (12–18) and 5 units avian myeloblastosis virus
reverse transcriptase at 50°C for 60 min, followed by heating to 85°C for 5 min.
Quantitative real-time RT-PCRs. Quantitative (q) real-time RT-PCRs for
TRPC1, TRPC3, TRPC5, TRPC6, TRP melastatin type 6 (TRPM6), TRPM7,
TNF-, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were per-
formed using a LightCycler-FastStart DNA Master SYBR Green I Kit (Roche
Diagnostics). The primers were as follows: TRPC1 (Reference Sequence
[RefSeq] database accession number: NM_003304.4), forward, 5TGCTTA
CCAAACTGCTGGTG3; reverse, 5AACTGTTTTGCCGTTTGACC3. TRPC3
(NM_003305), forward, 5GACTTTGGGATGCTGTCCAT3; reverse, 5GTAC
GCAATCCGAGAGAAGC3. TRPC5 (NM_012471.2), forward, 5CCACCAG
CTATCAGATAAGG3; reverse, 5CGAAACAAGCCACTTATACC3. TRPC6
(NM_004621), forward, 5GCCAATGAGCATCTGGAAAT3; reverse, 5TGGA
GTCACATCATGGGAGA3. TRPM6 (NM_017662.4), forward, 5TGATTCCTCT
CGGAGTGAACAGCAC3; reverse, 5TTATGATTGGCACCTGGAGTCCTTG3.
TRPM7 (NM_017672.3), forward, 5CTTATGAAGAGGCAGGTCATGG3; re-
verse, 5CATCTTGTCTGAAGGACTG3. TNF- (NM_000594.2), forward, 5CC
CAGGGACCTCTCTCTAATC3; reverse, 5ATGGGCTACAGGCTTGTCACT3.
GAPDH (NM_002046), forward, 5AACTGCTTAGCACCCCTGGC3; reverse,
5ATGACCTTGCCCACAGCCTT3. The expected and observed sizes of the
PCR products were (in bp) TRPC1 243; TRPC3 249; TRPC5 161; TRPC6 243;
TRPM6 347; TRPM7 214; TNF- 84; and GAPDH 200.
qRT-PCR was performed using 2 g RNA. LightCycler-FastStart DNA
Master SYBR Green I Kit and 500 nmol/l of each primer were used in a final
volume of 20 l. The reaction was initiated at 95°C for 10 min, followed by 40
cycles of denaturation at 95°C for 10 s; annealing for 10 s at 68°C (TRPM6), at
60°C (TRPC3, TRPM7, TNF-), at 57°C (TRPC1, TRPC6), or at 54°C (TRPC5,
GAPDH); and extension at 72°C for 15 s. Melting curve analysis was
performed from 65°C to 95°C with a heating rate of 0.1°C/s. Data were
recorded on a LightCycler 2.0 Instrument using LightCycler Software Version
4.0 (Roche Diagnostics).
The relative quantification method was used whereby the change in
expression of the target genes (TRPC1, TRPC3, TRPC5, TRPC6, TRPM6,
TRPM7, TNF-) relative to the housekeeping gene (GAPDH) was calculated.
Immunofluorescence assay of TRPC channel protein. For the identifica-
tion of TRPC channel proteins, quantitative in-cell Western assays of human
monocytes were performed using the Odyssey infrared imaging system (Licor
Biosciences, Bad Homburg, Germany). Human monocytes in 96-well plates
were incubated with rabbit anti-human TRPC3 or TRPC6 antibodies (1:1,000;
Alomone Labs, Jerusalem, Israel) for 2 h, washed, and incubated with
IRDye800-infrared fluorescent dye-conjugated sheep anti-rabbit antibodies
(1:1,000; Biomol, Hamburg, Germany) overnight at 4°C. Imaging was per-
formed at 810-nm emission with an excitation wavelength of 780 nm. Control
experiments were performed with omission of primary or secondary antibod-
ies. Conventional immunoblotting was performed as described previously by
our group (13).
Measurements of cytosolic calcium using fluorescent dye technique.
For ratiometric imaging experiments, monocytes were loaded with 2 mol/l of
the calcium-sensitive, cell-permeable, intracellular fluorescence dye 1-[2-(5-
carboxyoxazol-2-yl)-6-aminobenzofuran-5-oxy]-2-(2-amino-5-methyl-
phenoxy)-ethane-N,N,NN-tetra acetic acid penta acetoxymethyl ester (fura-
2/AM; Merck Biosciences, Darmstadt, Germany) at room temperature for 60
min and washed to remove extraneous dye. Fluorescence measurements were
performed in a temperature-controlled 96-well fluorescent plate reader at 37°C
(Fluoroskan Ascent Fluorometer; Thermo LabSystems Oy, Helsinki, Finland)
at 510-nm emission with excitation wavelengths of 340 and 380 nm. Baseline
fluorescence was measured for 10 min, and stable fluorescence readings were
obtained throughout. Calcium influx was activated after administration of
membrane-permeable 1-oleoyl-2-acetyl-sn-glycerol. We used the membrane-
permeable 2-aminoethoxydiphenylborane (2-APB) to inhibit calcium influx
through TRPC channels as previously described (15,16).
Measurements of reactive oxygen species using fluorescent dye tech-
nique. Monocytes were incubated with the dye 2,7-dichlorofluorescein
diacetate (DCF-DA, 50 mol/l) for 60 min and then were washed and
resuspended in Hanks’ balanced salt solution. DCF-DA is a nonpolar com-
pound that readily diffuses into cells, where it is hydrolyzed to the nonfluo-
rescent polar derivative DCFH and thereby trapped within the cells. In the
presence of reactive oxygen species, DCFH is oxidized to the highly fluores-
cent DCF, which was monitored spectrophotometrically at 530 nm with an
excitation wavelength of 485 nm.
Statistics. All values are reported as mean  SEM of at least four indepen-
dent experiments. Comparisons between groups were analyzed using non-
parametric Mann-Whitney test (GraphPad Prism 5.0; GraphPad Software, La
Jolla, CA). Data from multiple groups were analyzed using the nonparametric
Kruskal-Wallis and Dunn multiple comparison post hoc test. The numbers
given indicate the number of separate experiments. Each sample was tested in
duplicate. Two-sided P values 0.05 were considered to indicate statistical
significance. Where error bars do not appear on the figure, error was within
the symbol size.
RESULTS
High D-glucose increased reactive oxygen species in
human monocytes. The induction of reactive oxygen
species by high glucose was investigated using the dye
DCF-DA. Compared with control conditions (D-glucose,
5.6 mmol/l), the administration of 30 mmol/l D-glucose for
90 min significantly increased reactive oxygen species
from 1.0  0.01 to 1.84  0.17 arbitrary units [AU] (P 
0.01). Furthermore, the effect of D-glucose was blocked by
the concurrent administration of the superoxide dis-
mutase mimetic TMP (100 mol/l) to 0.78  0.07 AU (P 
0.01 compared with D-glucose alone).
Detection of TRP mRNA using qRT-PCR. To investi-
gate whether high glucose–induced oxidative stress may
affect TRP channels, we first analyzed TRP mRNA in
human monocytes from healthy control subjects using
qRT-PCR. The melting curve analysis showed the presence
of one single peak in monocytes after 4-h treatment under
control conditions, with high glucose or ONOO. The
expected and observed product sizes using gel electro-
phoresis were (in bp) TRPC1 243; TRPC3 249; TRPC5 161;
TRPC6 243; TRPM6 347; TRPM7 214; and GAPDH 200.
High D-glucose and oxidative stress increased TRP
mRNA in monocytes. We determined the effects of high
glucose and oxidative stress on TRPC3 and TRPC6 mRNA
in human monocytes. As shown in Fig. 1, compared with
control conditions with 5.6 mmol/l D-glucose, administra-
tion of high D-glucose (30 mmol/l) significantly increased
TRPC3 mRNA by 1.55-fold (P  0.01; n  6) and TRPC6
mRNA by 2.58-fold (P  0.01; n  12). The administration
of high L-glucose (30 mmol/l) did not significantly affect
TRPC3 or TRPC6 mRNA. Concurrent administration of
superoxide dismutase mimetic TMP (final concentration
100 mol/l) blocked the stimulating effect of high D-
glucose on TRPC3 and TRPC6 mRNA expression, indicat-
ing that high D-glucose causes its effects by increased
oxidative stress. Compared with control conditions, oxi-
dative stress induced by 100 mol/l ONOO also signifi-
cantly increased the TRPC3 mRNA by 1.77-fold (P  0.01;
n  15) and TRPC6 mRNA by 3.47-fold (P  0.01; n  11).
The administration of high D-glucose significantly in-
creased mRNA from TRPC1, TRPC5, TRPM6, or TRPM7
by 1.81-, 3.10-, 7.22-, or 7.99-fold compared with control
conditions, respectively (each P  0.05; n  4). The
administration of ONOO significantly increased mRNA
from TRPC1, TRPC5, TRPM6, or TRPM7 by 4.57-, 3.53-,
12.91-, or 3.51-fold, respectively (each P 0.05; n 4). We
now investigated whether upregulated TRP expression
was associated with elevated monocyte inflammatory gene
expression. Indeed, after the administration of high D-
glucose or ONOO and upregulation of TRP channels,
mRNA of the inflammatory cytokine TNF- was also
T. WUENSCH AND ASSOCIATES
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significantly increased by 6.11- or 2.32-fold (each P  0.05;
n  4), respectively.
Next, we evaluated whether induction of oxidative
stress by several pathways may affect TRPC expression.
Induction of oxidative stress using lipopolysaccharide
significantly increased TRPC3 mRNA expression in mono-
cytes from 1.00 0.48 to 9.60 0.40 (each n 5; P 0.05)
and TRPC6 mRNA expression from 1.00  0.23 to 3.90 
0.11 (each n  5; P  0.05). It is known that TNF-–
induced activation of NADPH oxidase increases superox-
ide radicals (17). TNF- significantly increased TRPC3
mRNA expression in monocytes from 1.00 0.01 to 1.58
0.21 (each n  4; P  0.05) and TRPC6 mRNA expression
from 1.00  0.00 to 1.32  0.08 (each n  4; P  0.05). In
agreement with these findings, the reduction of superox-
ide radicals using diphenylene iodonium (18) significantly
reduced TRPC3 mRNA expression in monocytes from
1.00  0.06 to 0.52  0.05 (each n  5; P  0.05) and
TRPC6 mRNA expression from 1.00  0.12 to 0.36  0.03
(each n 5; P 0.05). These data indicate that TRPC3 and
TRPC6 mRNA are regulated by oxidative stress, in partic-
ular by superoxide radicals.
We also investigated a possible role of phospholipase C
on glucose-induced TRPC expression. Compared with
control conditions, the inhibition of phosphatidylcholine-
specific phospholipase C by D609, or the inhibition of
phospholipase C activation by U73122, did not signifi-
cantly affect high D-glucose–induced TRPC3 mRNA ex-
pression (control 1.00  0.01; high D-glucose 1.57  0.10
[P  0.05 compared with control]; high D-glucose plus
D609 1.47  0.03 [not significant compared with high
D-glucose alone]; high D-glucose plus U73122 1.95  0.03
[not significant compared with high D-glucose alone]; each
n  4). It is known that TRPC-induced calcium influx is
regulated by phospholipase C. However, phospholipase C
seems not to be involved in glucose-induced upregulation
of TRPC mRNA expression.
To evaluate whether increased TRPC mRNA is a feature
of diabetes, we compared TRPC1, TRPC3, TRPC5, and
TRPC6 mRNA in monocytes from 18 patients with type 2
diabetes (10 women, 8 men; mean age 57  5 years;
systolic blood pressure 133  3 mmHg; diastolic blood
pressure 79  2 mmHg; serum sodium 135  1 mmol/l;
serum potassium 4.4  0.1 mmol/l; hemoglobin 11.2  0.5
g/dl; A1C 7.5  0.3%) and from 28 age-matched control
subjects (10 women, 18 men; mean age 56  4 years;
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FIG. 1. Changes of mRNA expression of (A) TRPC3, (B) TRPC6, (C
and D) TRPC1, TRPC5, TRPM6, TRPM7, and TNF- induced by high
glucose and ONOO. Exposure of monocytes to high glucose (HG; 30
mmol/l D-glucose) or ONOO (100 mol/l) for 4 h significantly in-
creased the TRPC3 and TRPC6 mRNA expression. The effect of high
glucose is attenuated by superoxide dismutase mimetic TMP (100
mol/l). Administration of L-glucose showed no significant effect.
Control (open bar) indicates control glucose (5.6 mmol/l D-glucose).
The expression of each factor is normalized to GAPDH expression.
Data are mean  SEM from at least four to six independent experi-
ments. *P < 0.05; **P < 0.01 compared with control conditions. E: Bar
graph showing TRPC3 mRNA and TRPC6 mRNA expression (normal-
ized ratio) in monocytes from 28 age-matched control subjects (open
bars) and from 18 patients with type 2 diabetes (filled bars). *P< 0.05
compared with control.
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systolic blood pressure 132  4 mmHg; diastolic blood
pressure 81  2 mmHg; serum sodium 136  1 mmol/l;
serum potassium 4.4  0.2 mmol/l; hemoglobin 12.3  0.5
g/dl; A1C 5.6  0.1%). TRPC6 mRNA was significantly
higher in monocytes from patients with type 2 diabetes
compared with control subjects (TRPC6 normalized ratio
0.028  0.014 [n 18] vs. 0.015  0.006 [n 28]; P 0.05;
Fig. 1E). On the other hand, TRPC1, TRPC3, or TRPC5
mRNA was not significantly different between the two
groups (TRPC1 0.025  0.012 vs. 0.025  0.006 [P  0.62];
TRPC3 0.010  0.005 vs. 0.003  0.001 [P  0.40]; TRPC5
0.007  0.004 vs. 0.003  0.001 [P  0.83]). These data
support the view that increased TRPC6 expression is a
characteristic feature of peripheral blood cells from pa-
tients with type 2 diabetes.
High D-glucose and oxidative stress increased TRPC3
and TRPC6 protein expression in monocytes. TRPC
protein expression in monocytes was quantified using a
quantitative in-cell Western assay. As shown in Fig. 2,
compared with control conditions with 5.6 mmol/l D-
glucose, administration of high D-glucose (30 mmol/l)
significantly increased TRPC3 protein expression by 1.58-
fold (P  0.01; n  10) and TRPC6 protein expression by
1.57-fold (P  0.01; n  8). The administration of high
L-glucose (30 mmol/l) did not significantly affect TRPC3 or
TRPC6 protein expression. Concurrent administration of
TMP (100 mol/l) blocked the stimulating effect of high
D-glucose on TRPC3 and TRPC6 protein expression.
Compared with control conditions, oxidative stress
induced by 100 mol/l ONOO also significantly in-
creased the TRPC3 protein expression by 1.70-fold (P 
0.01; n  9) and TRPC6 protein expression by 1.8-fold
(P  0.01; n  9).
High D-glucose–induced oxidative stress promoted
increased TRPC-mediated calcium influx. Cytosolic
calcium was measured in fura-2–loaded monocytes. 1-
Oleoyl-2-acetyl-rac-glycerol (OAG) increased cytosolic cal-
cium to 2.41 0.01 (n 15), whereas OAG in the presence
of high D-glucose increased cytosolic calcium to 2.79 
0.03 (n  14; P  0.01). Furthermore, it should be noted
that concurrent preincubation of cells with TMP (100
mol/l) and high D-glucose normalized OAG-induced cal-
cium influx (2.49  0.02; n  13; not significant compared
with control). Representative traces are shown in Fig. 3A.
These data indicate that high D-glucose–associated oxida-
tive stress promotes increased TRPC-mediated calcium
influx.
After treatment of monocytes with high D-glucose for
4 h, the administration of ONOO subsequently increased
intracellular calcium levels. In the presence of a mem-
brane-permeable TRPC blocker, 2-APB, the ONOO-in-
duced calcium increase was significantly attenuated
(3.99  0.05 vs. 4.56  0.04; each n  15; P  0.01
compared with ONOO alone; Fig. 3B).
DISCUSSION
Our present data show that high D-glucose–induced oxida-
tive stress causes increased TRP expression and calcium
influx in human monocytes. An increased calcium influx
through TRP channels may be responsible for an increased
activation of monocytes and enhanced atherosclerosis in
patients with diabetes.
The presence of high glucose levels is a characteristic
feature of diabetes and is considered a major pathogenic
factor for increased atherosclerosis and consecutive dis-
eases including cardiovascular disease (19). Both an in-
creased activation of monocytes and an increased
generation of reactive oxygen species in monocytes have
been described in patients with diabetes (6,20). The pro-
duction of mitochondrial superoxide has been implicated
as a major underlying mechanism linking high glucose and
cellular dysfunction (21,22). In the present study, we
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FIG. 2. Quantitative in-cell Western assay of TRPC3 and TRPC6
channel protein expression in monocytes treated with HG (30 mmol/l
D-glucose) in the absence and presence of TMP (100 mol/l), ONOO
(100 mol/l), L-glucose (30 mmol/l), or control (5.6 mmol/l D-glucose).
A: Representative conventional Western assay (TRPC3 protein and
GAPDH protein for loading control with top values indicating densito-
metric analysis of blots). The TRPC3/GAPDH ratio (fold over control)
is also indicated. B and D: Representative in-cell Western assays and
(C and E) summary data are shown. Data are means  SEM from at
least eight independent experiments. **P < 0.01 compared with con-
trol conditions.
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confirmed that high glucose increases reactive oxygen
species in monocytes. The high glucose–induced increase
of reactive oxygen species was blocked by the superoxide
dismutase mimetic TMP.
Activated monocytes in patients with diabetes are char-
acterized by increased calcium concentrations (9–11).
According to our present results, increased TRPC channel
expression in monocytes may be responsible for an in-
creased calcium influx after high glucose–induced oxida-
tive stress. We observed that high D-glucose–induced
oxidative stress increased the expression of both TRPC3
and TRPC6 mRNA and TRPC3 and TRPC6 channel pro-
teins in monocytes. The stimulating effect of high glucose
could be blocked by concurrent administration of TMP,
supporting the relevance of increased oxidative stress
after high D-glucose. Recently, Shanmugam et al. (23)
showed that exposure of monocytes to high glucose
increased the expression of several inflammatory cyto-
kines, including TNF- in an oxidant stress–dependent
manner. Our present results support these findings, indi-
cating that high glucose–induced upregulation of TRP
expression was associated with enhanced mRNA levels of
the inflammatory cytokine TNF-. We observed that high
glucose elevates the expression of TNF- even higher than
ONOO. The increased TNF- response after high glucose
compared with ONOO indicates that irrespective of oxida-
tive stress, other pathways (e.g., the polyol pathway)
contribute to increased inflammatory response in diabetes
(24). Taken together, high glucose–induced oxidative
stress activates monocytes by enhancing inflammatory
cytokines and TRP channel expression promoting trans-
membrane calcium influx. Indeed, our experiments using
the fluorescent dye fura-2 showed that high glucose–
induced oxidative stress promotes increased TRP-medi-
ated calcium influx.
Balzer et al. (25) suggested that TRPC channels are the
molecular basis of oxidant-activated cation channels in
endothelial cells. Poteser et al. (26) reported that redox
modulation of TRPC channels is responsible for oxidative
stress–induced changes in cytosolic calcium signaling. The
present study extends their findings, showing that oxida-
tive stress increased the expression of both TRPC3 and
TRPC6 mRNA and proteins. Therefore, high glucose–
induced oxidative stress in patients with diabetes may
activate monocytes both by interaction with TRPC chan-
nels and by enhanced TRPC expression. The present study
indicates that induction of oxidative stress by several
pathways may affect TRP expression. Induction of oxida-
tive stress using lipopolysaccharide- or TNF-–induced
activation of NADPH oxidase significantly increased
TRPC3 mRNA expression, whereas the reduction of super-
oxide radicals using diphenylene iodonium significantly
reduced TRPC3 mRNA expression. In the present study,
we also confirmed that high D-glucose–induced oxidative
stress increases TRPM6 and TRPM7 mRNA expression in
agreement with data from Yamamoto et al. (27), who
showed the regulation of TRPM expression by oxidative
stress.
To evaluate whether increased TRPC mRNA is a feature
of diabetes, we also compared TRPC mRNA in monocytes
from patients with type 2 diabetes and control subjects.
We observed increased TRPC6 mRNA in monocytes from
patients with type 2 diabetes. Increased TRPC6 protein
expression has already been reported in platelets from
patients with diabetes compared with control subjects
(28), supporting the view that increased TRPC6 expres-
sion is a characteristic feature of peripheral blood cells
from patients with diabetes. Furthermore, Hu et al. (29)
showed increased TRPC6 expression in the adrenal me-
dulla from Ossabaw miniature pigs with pre-diabetic met-
abolic syndrome. The effects of high glucose could be cell
specific. For example, Graham et al. (30) showed that high
glucose downregulates TRPC6 in cultured mesangial cells.
However, differences might be explained in part by use of
native blood cells and cultured cells. In our study, inhibi-
tion of phospholipase C did not affect TRPC mRNA
expression. However, several pathways including phos-
pholipase C, protein kinase C, or phosphatidylinositol
3-kinase may modulate TRP channel protein expression
and function, as suggested by recent literature (31–33).
In conclusion, the present study shows that high glu-
cose–induced oxidative stress increases TRPC3 and
TRPC6 channel expression and calcium influx in human
monocytes. These data point to a novel pathway for an
increased activation of monocytes and hence atheroscle-
rosis in patients with diabetes.
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